Advertisement

Diabetology International

, Volume 7, Issue 1, pp 34–41 | Cite as

Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level

  • Yukihiro BandoEmail author
  • Hitomi Wakaguri
  • Keiko Aoki
  • Hideo Kanehara
  • Azusa Hisada
  • Kazuhiro Okafuji
  • Daisyu Toya
  • Nobuyoshi Tanaka
Original Article
  • 139 Downloads

Abstract

Aim

To determine whether non-high-density lipoprotein cholesterol (non-HDL-C) level, in comparison with low-density lipoprotein cholesterol (LDL-C) level, is useful for predicting the values of various surrogate atherosclerosis markers in Japanese subjects with type 2 diabetes (T2DM).

Methods

Data were retrieved from medical records of 265 subjects with T2DM who underwent laboratory tests to evaluate for atherosclerosis by using the following parameters: brachial-ankle pulse wave velocity, mean and maximum carotid intima-media thickness (mean CIMT and max-CIMT), and ankle-brachial index, with simultaneous fasting blood sampling for routine lipid parameters.

Results

In a multiple stepwise regression analysis, non-HDL-C level, but not LDL-C level, positively correlated with max-CIMT (β coefficient = 0.14, F = 6.84). Stepwise logistic regression analysis revealed that a 0.26 mmol/L (10 mg/dL) increase in non-HDL-C level, but not LDL-C level, was significantly associated with high risk of max-CIMT (≥1.1 mm; odds ratio, 1.096; 95 % confidence interval, 1.003–1.202; p = 0.046). However, in a receiver operating characteristic curve (ROC) analysis, the addition of non-HDL-C level to the three significant independent variables obtained from the stepwise analyses did not significantly increased the area under the ROC curve (from 0.7789 to 0.7864, p = 0.4343).

Conclusions

Non-HDL-C levels may be non-inferior to LDL-C level for the prediction of high-risk max-CIMT in Japanese subjects with T2DM.

Keywords

Non-HDL cholesterol LDL cholesterol Maximum carotid intima-media thickness Type 2 diabetes 

Notes

Acknowledgments

The authors would like to thank their current and former colleagues in the Department of Internal Medicine at Fukui-ken Saiseikai Hospital for their assistance in the completion of this study.

Conflict of interest

None of the authors has conflicts of interest to declare.

Human rights statement and informed consent

All procedures conducted in this study were in accordance with the ethics committee of Fukui-ken Saiseikai Hospital and with the Helsinki Declaration of 1964 and later revision. Informed consent or substitute for it was obtained from all patients for being included in the study. Identifying information of patients of human subjects, including names, initials, addresses, admission dates, hospital numbers, or any other data that might identify patients were not included in our written descriptions.

References

  1. 1.
    Frost PH, Havel RJ. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiology. 1998;81:26B–31B.CrossRefGoogle Scholar
  2. 2.
    Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan–2012 version. J Atheroscler Thromb. 2014;21:93–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMedGoogle Scholar
  4. 4.
    Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:1413–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875–81.CrossRefPubMedGoogle Scholar
  6. 6.
    Goliasch G, Oravec S, Blessberger H, Dostal E, Hoke M, Wojta J, Schillinger M, Huber K, Maurer G, Wiesbauer F. Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤40 years of age). Eur J Clin Invest. 2012;42:631–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Holme I, Aastveit AH, Jungner I, Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2008;264:30–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Keys A, Karvonen MJ, Pnsar S, Menotti A, Fidanza F, Farchi G. HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol. 1984;13:428–35.CrossRefPubMedGoogle Scholar
  9. 9.
    Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes. 1997;46:1354–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Liu J, Sempos CT, Donahue RP, Dom J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol. 2006;98:1363–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Menotti A, Spagnolo A, Scanga M, Dima F. Multivariate prediction of coronary deaths in a 10-year follow-up of an Italian occupational male cohort. Acta Cardiol. 1992;47:311–20.PubMedGoogle Scholar
  12. 12.
    Menotti A, Kromhout D, Nissinen A, Giampaoli S, Seccareccia F, Feskens E, Pekkanen J, Tervahauta M. Short-term all-cause mortality and its determinants in elderly male populations in Finland, the Netherlands, and Italy: the FINE Study. Prev Med. 1996;25:319–26.CrossRefPubMedGoogle Scholar
  13. 13.
    Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112:3375–83.CrossRefPubMedGoogle Scholar
  14. 14.
    Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Bittner V, Hardison R, Kelsey SF, Weiner BH, Jacobs AK, Sopko G. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angiography Revascularization Investigation (BARI). Circulation. 2002;1016:2537–42.CrossRefGoogle Scholar
  16. 16.
    Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein management in patients with cardiomeabolic risk: consensus conference report from American Diabetes Association and American College of Cardiology Foundation. J Am Coll Cardiol. 2008;51:1512–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefPubMedGoogle Scholar
  18. 18.
    Gu DF, Hinks LJ, Morton NE, Day IN. The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit. Ann Hum Genet. 2000;64:383–90.CrossRefPubMedGoogle Scholar
  19. 19.
    Katakami N, Kaneto H, Osonoi T, Saitou M, Takahara M, Sakamoto F, Yamamoto K, Yasuda T, Matsuoka TA, Matsuhisa M, Yamasaki Y, Shimomura I. Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients. Atherosclerosis. 2010;214:442–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, Yoneda S, Kimura K, Kamada T. Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 1990;21:1567–72.CrossRefPubMedGoogle Scholar
  21. 21.
    Li R, Duncan BB, Metcalf PA, Crouse JR III, Sharrett AR, Tyroler HA, Barnes R, Heiss G. B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;25:2377–83.CrossRefPubMedGoogle Scholar
  22. 22.
    O’Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, Bommer W, Price TR, Gardin JM, Savage PJ. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke. 1992;23:1752–60.CrossRefPubMedGoogle Scholar
  23. 23.
    Suzuki E, Kashiwagi A, Nishio Y, Egawa K, Shimizu S, Maegawa H, Haneda M, Yasuda H, Morikawa S, Inubushi T, Kikkawa R. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care. 2001;24:2107–14.CrossRefPubMedGoogle Scholar
  24. 24.
    Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of non-invasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25:359–64.CrossRefPubMedGoogle Scholar
  25. 25.
    Shimizu H, Shimomura K, Negishi M, Uehara Y, Mori M. Changes of pulse wave velocity (PWV) for 12 months in type 2 diabetic patients. 26th International Congress of Internal Medicine, Kyoto, Japan; 2002 (Abstract).Google Scholar
  26. 26.
    Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart. 2004;90:1286–90.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kotsis VT, Pitiriga VCh, Stabouli SV, Papamichael CM, Toumanidis ST, Rokas SG, Zakopoulos NA. Carotid artery intima-media thickness could predict the presence of coronary artery lesions. Am J Hypertens. 2005;18:601–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–67.CrossRefPubMedGoogle Scholar
  29. 29.
    Irie Y, Katakami N, Kaneto H, Kasami R, Sumitsuji S, Yamasaki K, Tachibana K, Kuroda T, Sakamoto K, Umayahara Y, Ueda Y, Kosugi K, Shimomura I. Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease. Atherosclerosis. 2012;221:438–44.CrossRefPubMedGoogle Scholar
  30. 30.
    Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, Horio T, Kawano Y. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens. 2004;18:17–23.CrossRefPubMedGoogle Scholar
  31. 31.
    Irie Y, Katakami N, Kaneto H, Nishio M, Kasami R, Sakamoto K, Umayahara Y, Sumitsuji S, Ueda Y, Kosugi K, Shimomura I. The utility of carotid ultrasonography in identifying severe coronary artery disease in asymptomatic type 2 diabetes patients without history of coronary artery disease. Diabetes Care. 2013;36:1327–34.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care. 2004;27:1991–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care. 2005;28:1916–21.CrossRefPubMedGoogle Scholar
  34. 34.
    Sattar N, Williams K, Sniderman AD, D’Agostino R Jr, Haffner SM. Comparison of the associations of apoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation. 2004;110:2687–93.CrossRefPubMedGoogle Scholar
  35. 35.
    Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dysproteinemia in type 2 diabetes mellitus. Ann Intern Med. 2001;135:447–59.CrossRefPubMedGoogle Scholar
  36. 36.
    Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:1328–36.CrossRefPubMedGoogle Scholar
  37. 37.
    Berry CL, Greenwald SE. Effects of hypertension on the static mechanical properties and chemical composition of the rat aorta. Cardiovasc Res. 1976;10:437–51.CrossRefPubMedGoogle Scholar
  38. 38.
    Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999;30:841–50.CrossRefPubMedGoogle Scholar
  39. 39.
    Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 1991;293:225–31.CrossRefGoogle Scholar
  40. 40.
    Hayase T, Ayaori M, Sato H, Tanaka N, Ohashi K, Uto-Kondo H, Ikewaki K, Ohsuzu F. Impact of low-and high-density lipoprotein cholesterol levels on carotid intima-media thickness differs by smoking status in middle-aged men. J Atheroscler Thromb. 2012;19:664–72.CrossRefPubMedGoogle Scholar

Copyright information

© The Japan Diabetes Society 2015

Authors and Affiliations

  • Yukihiro Bando
    • 1
    Email author
  • Hitomi Wakaguri
    • 1
  • Keiko Aoki
    • 1
  • Hideo Kanehara
    • 1
  • Azusa Hisada
    • 1
  • Kazuhiro Okafuji
    • 1
  • Daisyu Toya
    • 1
  • Nobuyoshi Tanaka
    • 1
  1. 1.Department of Internal MedicineFukui-ken Saiseikai HospitalFukuiJapan

Personalised recommendations